Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial
Journal of the American Academy of Dermatology | Feb 09, 2018
Most read this week
Journal of the American Academy of Dermatology | Feb 09, 2018